Specifically, ubiquitination of oncoproteins and deubiquitination of tumor suppressor proteins may lead to tumorigenesis suppression, tumor progression, cancer metabolism, and chemotherapy or radiotherapy resistance, whereas deubiquitination of oncoproteins causes cancer by prolonging the half-life of oncoproteins [62,89,92]. This evidence concerns the gene TCHP and cancer.